The Valley Desk

NCT00012467 · Interventional trial

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Overall registry status Completed

Phase 2

Conditions HIV Infections, Meningitis, Cryptococcal

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov